Hua‐Zhen Xu
- Biomedical Engineering top 10%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Immunology
- Materials Chemistry
- Co-authors
- Xiao ChenTong‐Fei LiLi ZhaoXing‐Chun PengNing HanLiu‐Gen LiTingting YuXiang Xu
- Topics
- Nanoplatforms for cancer theranostics (15 papers)Immune cells in cancer (10 papers)Photodynamic Therapy Research Studies (7 papers)
- Journals
- Advanced MaterialsNature CommunicationsSHILAP Revista de lepidopterología
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Hua‐Zhen Xu
36 papers receiving 806 citations
Peers
Comparison fields: 5 of 88
- Biomedical Engineering 348
- Molecular Biology 302
- Pulmonary and Respiratory Medicine 243
- Immunology 171
- Materials Chemistry 150
Countries citing papers authored by Hua‐Zhen Xu
This map shows the geographic impact of Hua‐Zhen Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hua‐Zhen Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hua‐Zhen Xu more than expected).
Fields of papers citing papers by Hua‐Zhen Xu
This network shows the impact of papers produced by Hua‐Zhen Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hua‐Zhen Xu. The network helps show where Hua‐Zhen Xu may publish in the future.
Co-authorship network of co-authors of Hua‐Zhen Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Hua‐Zhen Xu. A scholar is included among the top collaborators of Hua‐Zhen Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hua‐Zhen Xu. Hua‐Zhen Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 14 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 5 | |
| 7 | 14 | |
| 8 | 6 | |
| 9 | 51 | |
| 10 | 6 | |
| 11 | 15 | |
| 12 | 49 | |
| 13 | 49 | |
| 14 | LINC00887 aggravates the malignant progression of glioma via upregulating CCND1 | 6 |
| 15 | 44 | |
| 16 | 14 | |
| 17 | 16 | |
| 18 | 17 | |
| 19 | 30 | |
| 20 | 61 |
About Hua‐Zhen Xu
Hua‐Zhen Xu is a scholar working on Immunology, Biomaterials and Cancer Research, having authored 38 papers that have together received 809 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (15 papers), Immune cells in cancer (10 papers) and Photodynamic Therapy Research Studies (7 papers). The work is most often cited by research in Biomaterials (120 citations), Cancer Research (132 citations) and Immunology (171 citations). Hua‐Zhen Xu has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Xiao Chen, Tong‐Fei Li, Li Zhao, Xing‐Chun Peng, Ning Han, Liu‐Gen Li, Tingting Yu, Xiang Xu, Yong‐Hong Xu and Qi‐Rui Li. Their work appears in journals such as Advanced Materials, Nature Communications and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.